Jong-Ho Hong
Chief Executive Officer bei KUKJEON PHARMACEUTICAL CO., LTD
Vermögen: 97 Mio $ am 31.03.2024
Profil
Jong-Ho Hong is currently the Chief Executive Officer at Kukjeon Pharm Co., Ltd.
and the Chief Executive Officer & Director at Kukjeon Pharmaceutical Co., Ltd.
He has a graduate degree from Sogang University and an undergraduate degree from Sungkyunkwan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.04.2024 | 21 373 361 ( 43,56% ) | 97 Mio $ | 31.03.2024 |
Aktive Positionen von Jong-Ho Hong
| Unternehmen | Position | Beginn |
|---|---|---|
| KUKJEON PHARMACEUTICAL CO., LTD | Chief Executive Officer | - |
Kukjeon Pharm Co., Ltd.
 Kukjeon Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Kukjeon Pharm Co., Ltd. manufactures medicines and antibiotics. The firm’s products include celecoxib, choline alfoscerate, dibucaine, enoxolone, eperisone HCL, epinastine HCL, hinokitiol and nizatidine. The company was founded on July 26, 1995 and is headquartered in Anyang-si, South Korea. | Chief Executive Officer | - |
Ausbildung von Jong-Ho Hong
| Sogang University | Graduate Degree |
| Sungkyunkwan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KUKJEON PHARMACEUTICAL CO., LTD | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Kukjeon Pharm Co., Ltd.
Kukjeon Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Kukjeon Pharm Co., Ltd. manufactures medicines and antibiotics. The firm’s products include celecoxib, choline alfoscerate, dibucaine, enoxolone, eperisone HCL, epinastine HCL, hinokitiol and nizatidine. The company was founded on July 26, 1995 and is headquartered in Anyang-si, South Korea. | Health Technology |
